FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2568884027> ?p ?o ?g. }

• W2568884027 endingPage "177" @default.
• W2568884027 startingPage "161" @default.
• W2568884027 abstract "To systematically review anatomical and functional outcomes subsequent to switching from bevacizumab/ranibizumab to aflibercept monotherapy in patients with treatment-resistant neovascular age-related macular degeneration (nAMD).Systematic review and meta-analysis.Medline, PubMed, Embase, and Cochrane databases were searched up to July 2016 for available scientific literature which met inclusion criteria. Eligible studies reported visual and anatomical outcomes with at least 6 months of follow-up among patients with nAMD and persistent or resistant exudative fluid despite previous anti-vascular endothelial growth factor (VEGF) therapy (bevacizumab and/or ranibizumab) and were switched to aflibercept monotherapy. Mean changes in best-corrected visual acuity (BCVA) and central retinal thickness (CRT) were pooled using random-effects models with 95% confidence intervals (CIs).Of 82 papers reviewed, 28 studies met inclusion criteria of this review. Pooled results showed a small mean improvement in BCVA at 6 and 12 months following switching (1.11 letters, 95% CI -0.25 to 2.46, P=0.17 and 0.63 letters, 95% CI -0.26 to 1.52, P=0.17, respectively). There was a significant improvement in mean CRT following switching (-61.90 µm, 95% CI -77.10 to -46.80, P<0.001 and -50.00 µm, 95% CI -63.20 to -36.80, P<0.001 at 6 and 12 months, respectively).Pooled analysis demonstrated significantly improved anatomical outcomes; however, visual function remained stable, having a comparable effect to other anti-VEGF agents in preservation of vision. These patients had poorly responsive chronic disease with limited potential for visual recovery. Switching to aflibercept with frequent monitoring may be a suitable option for patients who have developed treatment resistance." @default.
• W2568884027 created "2017-01-13" @default.
• W2568884027 creator A5022581226 @default.
• W2568884027 creator A5028010693 @default.
• W2568884027 creator A5036894328 @default.
• W2568884027 creator A5067329262 @default.
• W2568884027 date "2017-01-01" @default.
• W2568884027 modified "2023-10-12" @default.
• W2568884027 title "Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis" @default.
• W2568884027 cites W1179025270 @default.
• W2568884027 cites W1487528435 @default.
• W2568884027 cites W1500728559 @default.
• W2568884027 cites W1815853970 @default.
• W2568884027 cites W1935759885 @default.
• W2568884027 cites W1938534141 @default.
• W2568884027 cites W1964901573 @default.
• W2568884027 cites W1968189763 @default.
• W2568884027 cites W1969666792 @default.
• W2568884027 cites W1976005612 @default.
• W2568884027 cites W1979356478 @default.
• W2568884027 cites W1979831185 @default.
• W2568884027 cites W1980632047 @default.
• W2568884027 cites W1994426946 @default.
• W2568884027 cites W1997480136 @default.
• W2568884027 cites W1999167969 @default.
• W2568884027 cites W2000954383 @default.
• W2568884027 cites W2001456855 @default.
• W2568884027 cites W2003586642 @default.
• W2568884027 cites W2004117352 @default.
• W2568884027 cites W2022039498 @default.
• W2568884027 cites W2028771040 @default.
• W2568884027 cites W2037780881 @default.
• W2568884027 cites W2049577742 @default.
• W2568884027 cites W2050270337 @default.
• W2568884027 cites W2052840162 @default.
• W2568884027 cites W2053255808 @default.
• W2568884027 cites W2066605134 @default.
• W2568884027 cites W2070438736 @default.
• W2568884027 cites W2075978545 @default.
• W2568884027 cites W2084462826 @default.
• W2568884027 cites W2091243463 @default.
• W2568884027 cites W2092886764 @default.
• W2568884027 cites W2102167881 @default.
• W2568884027 cites W2114488753 @default.
• W2568884027 cites W2123096760 @default.
• W2568884027 cites W2125435699 @default.
• W2568884027 cites W2126930838 @default.
• W2568884027 cites W2131192872 @default.
• W2568884027 cites W2132849987 @default.
• W2568884027 cites W2134954483 @default.
• W2568884027 cites W2147577701 @default.
• W2568884027 cites W2160226180 @default.
• W2568884027 cites W2162055363 @default.
• W2568884027 cites W2169896524 @default.
• W2568884027 cites W2171338724 @default.
• W2568884027 cites W2186681554 @default.
• W2568884027 cites W2219900864 @default.
• W2568884027 cites W2235304655 @default.
• W2568884027 cites W2265147089 @default.
• W2568884027 cites W2285481994 @default.
• W2568884027 cites W2291188112 @default.
• W2568884027 cites W2299415664 @default.
• W2568884027 cites W2313043717 @default.
• W2568884027 cites W2319930158 @default.
• W2568884027 cites W2320987231 @default.
• W2568884027 cites W2398091945 @default.
• W2568884027 cites W2404703984 @default.
• W2568884027 cites W2412434883 @default.
• W2568884027 cites W2414824006 @default.
• W2568884027 cites W2418354957 @default.
• W2568884027 cites W2472181847 @default.
• W2568884027 cites W2517210752 @default.
• W2568884027 cites W362778470 @default.
• W2568884027 cites W4256101427 @default.
• W2568884027 cites W543922 @default.
• W2568884027 doi "https://doi.org/10.2147/opth.s125676" @default.
• W2568884027 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5229260" @default.
• W2568884027 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28123287" @default.
• W2568884027 hasPublicationYear "2017" @default.
• W2568884027 type Work @default.
• W2568884027 sameAs 2568884027 @default.
• W2568884027 citedByCount "41" @default.
• W2568884027 countsByYear W25688840272017 @default.
• W2568884027 countsByYear W25688840272018 @default.
• W2568884027 countsByYear W25688840272019 @default.
• W2568884027 countsByYear W25688840272020 @default.
• W2568884027 countsByYear W25688840272021 @default.
• W2568884027 countsByYear W25688840272022 @default.
• W2568884027 countsByYear W25688840272023 @default.
• W2568884027 crossrefType "journal-article" @default.
• W2568884027 hasAuthorship W2568884027A5022581226 @default.
• W2568884027 hasAuthorship W2568884027A5028010693 @default.
• W2568884027 hasAuthorship W2568884027A5036894328 @default.
• W2568884027 hasAuthorship W2568884027A5067329262 @default.
• W2568884027 hasBestOaLocation W25688840271 @default.
• W2568884027 hasConcept C118487528 @default.
• W2568884027 hasConcept C126322002 @default.
• W2568884027 hasConcept C2776403814 @default.

• next